<DOC>
	<DOCNO>NCT01352572</DOCNO>
	<brief_summary>The purpose study determine whether alteration signal transduction component antidepressant targeting , predict antidepressant responsiveness advance appearance drug effect 4~6 week drug administration , represent clinical status depress patient .</brief_summary>
	<brief_title>Effects Antidepressant Postsynaptic Signal Transduction Serotonergic System Depressed Patients</brief_title>
	<detailed_description>The purpose study determine whether antidepressant effect signal transduction peripheral lymphocyte determine whether signal difference drug responder nonresponders predict antidepressant response represent clinical status depress patient .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<mesh_term>Mirtazapine</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<mesh_term>Milnacipran</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<mesh_term>Nortriptyline</mesh_term>
	<criteria>1. meet Diagnostic Statistical Manual American Psychiatric Association ( DSMIV ) criteria MDD Department Psychiatry , Sungkyunkwan University , Seoul , South Korea . 2. 18 year age old , existence unipolar major depressive episode verify DSMIII/IV criterion , least 2 year first episode onset , agreement inform consent pregnancy significant medical condition abnormal laboratory baseline value unstable psychiatric feature ( e.g , suicidal attempt ) history alcohol drug dependence , seizure , neurological illness , concomitant Axis I psychiatric disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Antidepressant Response</keyword>
	<keyword>Signal Transduction</keyword>
	<keyword>Lymphocyte</keyword>
	<keyword>Biomarkers</keyword>
	<keyword>Depressed Patients</keyword>
	<keyword>Antidepressant Drug Adverse Reaction</keyword>
</DOC>